TREATMENT OF INFANTILE FACE HEMANGIOMAS WITH PROPRANOLOL
Ilya Vyacheslavovich Stepanov , D. Yu Haritonov , I. V Korytina , M. A Agapova , A. V Podoprigora
Russian Journal of Dentistry ›› 2019, Vol. 23 ›› Issue (5) : 212 -216.
TREATMENT OF INFANTILE FACE HEMANGIOMAS WITH PROPRANOLOL
The aim of the study was to increase the effectiveness of treatment of facial hemangiomas in children because of the usage of non-selective beta-blocker - propranolol in complex treatment. Materials and methods of research. 18 children under the age of 1 year with maxillofacial hemangiomas were observed. Localized hemangioma was observed in 38.8% (n=7). In 44.4% (n=8) hemangiomas occupied 2-3 adjacent anatomical areas. In 16.8% (n=3) hemangioma occupied more than 3 anatomical areas. For drug therapy of facial hemangiomas in children, non-selective beta - blockers - «Propranolol»were used. Results. The minimum course of treatment was 6 months, the average - 9 months, the maximum - 13. Treatment was completed in 11 (61.1%) children, 4 of them (22.2%) had involution of education. 2 (11.1%) were operated after a course of therapy of betablockers. 5 (27.8%), after 12 months of photothermolysis. Another 5 (27.8%) continue to receive drug therapy with non-selective beta-blockers to date. there is a positive dynamics, consisting in persistent degradation of tumor volume. All children had a significan t decrease in the area and volume of hemangioma. Summary. Localization of vascular tumors in the maxillofacial region, rapid growth, leading to irreversible functional and aestheti c disorders - is a direct indication for active therapy. Treatment of facial hemangiomas in children with non-selective beta-blockers as an independent method refers to the method of choice, in case of impossibility or high risk of surgical treatment, or is part of the combined treatment.
infantile hemangioma / propranolol / anaprilin / treatment of hemangiomas
| [1] |
Бережнова С.Г. Основные направления лечения гемангиом орбитальной и параорбитальной локализации у детей. Российский офтальмологический журнал. 2013; 6(1): 96-102. |
| [2] |
Нурмеева А.Р., Миролюбов А.Л., Нурмеев И.Н. Современные технологии в диагностике и лечении гемангиом. Фундаментальные исследования. 2013; 7: 356-9. |
| [3] |
Поляев Ю.А., Постников С.С., Мыльников А.А., Нарбутов А.Г. Место пропранолола в лечении инфантильных гемангиом. Детская больница. 2012; 4: 46-8. |
| [4] |
Степанов И.В., Ольшанский М.С., Харитонов Д.Ю., Коротких Н.Г. Патоморфологические изменения тканей гиперваскулярного образования на фоне эндоваскулярного лечения. Вестни к новых медицинских технологий. [Электронный журнал]. 2015;1:2-14. URL: http://www.medtsu.tula.ru/VNMT/Bulletin/ E2015-1/5133.pdf (дата обращения: 25.03.2015). https://doi.org/ 10.12737/10412. |
| [5] |
Чижевская И.Д. Неинвазивный метод лечения врожденных гемангиом челюстно-лицевой области у детей. Педиатрия. Восточная Европа. 2015; 3: 160-6. |
| [6] |
Шептий О.В., Круглова Л.С. Младенческая гемангиома: классификация, клиническая картина и методы коррекции. Российский журнал кожных и венерических болезней. 2016; 3: 178-83. |
| [7] |
Buckmiller L.M., Munson P.D., Dyamenahalli U., Dai Y., Richter G.T. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope. 2010; 120 (4): 676-81. https://doi.org/10.1002/lary.20807. |
| [8] |
Gey A., Ezzidine K., Diallo A. Stay in NICU and infantile haemangioma development. EADV. 2014;29:566-573. https://doi.org/ 10.1111/jdv.12639. |
| [9] |
Keller R.G. Patel K.G. Evidence-Based medicine in the treatment of infantile hemangiomas facial. Plast. Surg. Clin. North. Am. 2015; 23 (3): 373-92. https://doi.org/10.1016/j.fsc.2015.04.009. |
| [10] |
Mawn LA Infantile hemangioma: treatment with surgery or steroids. Am. Orthopt. J. 2013; 63: 6-13. https://doi.org/10.3368/aoj.63.1.6. |
Eco-Vector
/
| 〈 |
|
〉 |
PDF
